We established an ESCC cell line resistant to the chemotherapy drug Adriamycin to identify two highly expressed genes, the major vault protein (MVP) and the B-cell lymphoma-2 (BCL2) gene related to MDR [29, 30]. This evidence concerns the gene BCL2 and esophageal squamous cell carcinoma.